Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial

BACKGROUND: Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmeister, Jan, Holle, Dagny, Bock, Eva, Ose, Claudia, Diener, Hans-Christoph, Obermann, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669653/
https://www.ncbi.nlm.nih.gov/pubmed/26634453
http://dx.doi.org/10.1186/s13063-015-1052-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669653/
https://www.ncbi.nlm.nih.gov/pubmed/26634453
http://dx.doi.org/10.1186/s13063-015-1052-z

Ejemplares similares